Acute  ||| S:0 E:6 ||| JJ
disseminated  ||| S:6 E:19 ||| NNS
encephalomyelitis  ||| S:19 E:37 ||| VBP
associated  ||| S:37 E:48 ||| VBN
with  ||| S:48 E:53 ||| IN
hepatitis  ||| S:53 E:63 ||| NNP
B  ||| S:63 E:65 ||| NNP
virus  ||| S:65 E:71 ||| NN
reinfection--consequence  ||| S:71 E:96 ||| NN
or  ||| S:96 E:99 ||| CC
coincidence ||| S:99 E:110 ||| NN
?  ||| S:110 E:112 ||| .
Acute  ||| S:112 E:118 ||| FW
disseminated  ||| S:118 E:131 ||| FW
encephalomyelitis  ||| S:131 E:149 ||| FW
( ||| S:149 E:150 ||| -LRB-
ADEM ||| S:150 E:154 ||| NNP
)  ||| S:154 E:156 ||| -RRB-
is  ||| S:156 E:159 ||| VBZ
an  ||| S:159 E:162 ||| DT
idiopathic  ||| S:162 E:173 ||| JJ
inflammatory  ||| S:173 E:186 ||| JJ
demyelinating  ||| S:186 E:200 ||| JJ
disease  ||| S:200 E:208 ||| NN
of  ||| S:208 E:211 ||| IN
the  ||| S:211 E:215 ||| DT
CNS  ||| S:215 E:219 ||| NN
that  ||| S:219 E:224 ||| WDT
is  ||| S:224 E:227 ||| VBZ
particularly  ||| S:227 E:240 ||| RB
difficult  ||| S:240 E:250 ||| JJ
to  ||| S:250 E:253 ||| TO
differentiate  ||| S:253 E:267 ||| VB
from  ||| S:267 E:272 ||| IN
the  ||| S:272 E:276 ||| DT
first  ||| S:276 E:282 ||| JJ
episode  ||| S:282 E:290 ||| NN
of  ||| S:290 E:293 ||| IN
multiple  ||| S:293 E:302 ||| JJ
sclerosis ||| S:302 E:311 ||| NN
.  ||| S:311 E:313 ||| .
ADEM  ||| S:313 E:318 ||| NNP
typically  ||| S:318 E:328 ||| RB
occurs  ||| S:328 E:335 ||| VBZ
as  ||| S:335 E:338 ||| IN
a  ||| S:338 E:340 ||| DT
post-infectious  ||| S:340 E:356 ||| JJ
phenomenon ||| S:356 E:366 ||| NN
,  ||| S:366 E:368 ||| ,
and  ||| S:368 E:372 ||| CC
usually  ||| S:372 E:380 ||| RB
presents  ||| S:380 E:389 ||| VBZ
a  ||| S:389 E:391 ||| DT
monophasic  ||| S:391 E:402 ||| JJ
episode ||| S:402 E:409 ||| NN
,  ||| S:409 E:411 ||| ,
but  ||| S:411 E:415 ||| CC
also  ||| S:415 E:420 ||| RB
includes  ||| S:420 E:429 ||| VBZ
recurrent  ||| S:429 E:439 ||| JJ
and  ||| S:439 E:443 ||| CC
multiphasic  ||| S:443 E:455 ||| JJ
forms ||| S:455 E:460 ||| NNS
.  ||| S:460 E:462 ||| .
We  ||| S:462 E:465 ||| PRP
report  ||| S:465 E:472 ||| VBP
a  ||| S:472 E:474 ||| DT
case  ||| S:474 E:479 ||| NN
of  ||| S:479 E:482 ||| IN
ADEM  ||| S:482 E:487 ||| NNP
associated  ||| S:487 E:498 ||| VBN
with  ||| S:498 E:503 ||| IN
hepatitis  ||| S:503 E:513 ||| NNP
B  ||| S:513 E:515 ||| NNP
virus  ||| S:515 E:521 ||| NN
( ||| S:521 E:522 ||| -LRB-
HBV ||| S:522 E:525 ||| NNP
)  ||| S:525 E:527 ||| -RRB-
reinfection ||| S:527 E:538 ||| NN
.  ||| S:538 E:540 ||| .
After  ||| S:540 E:546 ||| IN
steroid  ||| S:546 E:554 ||| NN
and  ||| S:554 E:558 ||| CC
IV  ||| S:558 E:561 ||| NNP
immunoglobulin  ||| S:561 E:576 ||| JJ
treatment ||| S:576 E:585 ||| NN
,  ||| S:585 E:587 ||| ,
neurologic  ||| S:587 E:598 ||| JJ
symptoms  ||| S:598 E:607 ||| NNS
were  ||| S:607 E:612 ||| VBD
improved ||| S:612 E:620 ||| VBN
.  ||| S:620 E:622 ||| .
We  ||| S:622 E:625 ||| PRP
suppose  ||| S:625 E:633 ||| VBP
that  ||| S:633 E:638 ||| IN
the  ||| S:638 E:642 ||| DT
HBV  ||| S:642 E:646 ||| NNP
reinfection  ||| S:646 E:658 ||| NN
was  ||| S:658 E:662 ||| VBD
the  ||| S:662 E:666 ||| DT
cause  ||| S:666 E:672 ||| NN
of  ||| S:672 E:675 ||| IN
ADEM ||| S:675 E:679 ||| NNP
,  ||| S:679 E:681 ||| ,
but  ||| S:681 E:685 ||| CC
possible  ||| S:685 E:694 ||| JJ
pathogenetic  ||| S:694 E:707 ||| JJ
mechanism  ||| S:707 E:717 ||| NN
is  ||| S:717 E:720 ||| VBZ
still  ||| S:720 E:726 ||| RB
obscure ||| S:726 E:733 ||| JJ
.  ||| S:733 E:735 ||| .
